Cargando…

The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies

BACKGROUND: High-grade primary and metastatic central nervous system (CNS) tumors are common, deadly, and refractory to conventional therapy and continue to be therapeutically challenging. A key nodal transcriptional factor, the signal transducer and activator of transcription 3 (STAT3), drives the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Heimberger, Amy B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228387/ https://www.ncbi.nlm.nih.gov/pubmed/22140648 http://dx.doi.org/10.4103/2152-7806.89886

Ejemplares similares

Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma
por: de Groot, John, et al.
Publicado: (2012)

LMD-20. Immune Suppressive Macrophages and Signal Transducer and Activator of Transcription 3 (STAT3) Expression are common in Melanoma Leptomeningeal Disease
por: Najem, Hinda, et al.
Publicado: (2021)

Physiological functions of endoplasmic reticulum stress transducer OASIS in central nervous system
por: Saito, Atsushi
Publicado: (2013)

Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system
por: Wei, Jun, et al.
Publicado: (2022)

The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies
por: Arora, Loukik, et al.
Publicado: (2018)

Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target
por: Wang, Hua, et al.
Publicado: (2011)

CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease
por: Najem, Hinda, et al.
Publicado: (2021)

Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
por: Ogura, Michinori, et al.
Publicado: (2015)

Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers
por: Gurunathan, Sangiliyandi, et al.
Publicado: (2020)

Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors
por: Furtek, Steffanie L., et al.
Publicado: (2016)

Mitochondrial transplantation strategies as potential therapeutics for central nervous system trauma
por: Gollihue, Jenna L., et al.
Publicado: (2018)

A potential therapeutic target: The role of neutrophils in the central nervous system
por: Salken, Isabel, et al.
Publicado: (2023)

Therapeutic Targeting of STAT3 (Signal Transducers and Activators of Transcription 3) Pathway Inhibits Experimental Autoimmune Uveitis
por: Yu, Cheng-Rong, et al.
Publicado: (2012)

Hybridization Approach to Identify Salicylanilides as Inhibitors of Tubulin Polymerization and Signal Transducers and Activators of Transcription 3 (STAT3)
por: Gargantilla, Marta, et al.
Publicado: (2022)

Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO‐1701
por: Nishisaka, Fukiko, et al.
Publicado: (2020)

γ-tubulin as a signal-transducing molecule and meshwork with therapeutic potential
por: Alvarado-Kristensson, Maria
Publicado: (2018)

Palliative Care for Children with Central Nervous System Malignancies
por: Baenziger, Peter H., et al.
Publicado: (2018)

Heme Oxygenase-1 in Central Nervous System Malignancies
por: Sferrazzo, Giuseppe, et al.
Publicado: (2020)

Current Understanding of Circulating Tumor Cells – Potential Value in Malignancies of the Central Nervous System
por: Adamczyk, Lukasz A., et al.
Publicado: (2015)

Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication
por: Loh, Chin-Yap, et al.
Publicado: (2019)

The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases
por: Zuo, Shilun, et al.
Publicado: (2016)

Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders
por: Hong, Hongxiang, et al.
Publicado: (2022)

Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
por: Huang, Yinrou, et al.
Publicado: (2023)

The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases
por: Tan, Rui, et al.
Publicado: (2023)

Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3
por: Cui, Xiangrong, et al.
Publicado: (2014)

Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma
por: Litonjua, Augusto A, et al.
Publicado: (2005)

Signal transducer and activator of transcription 3 mutation with invasive eosinophilic disease
por: Crosby, Kara, et al.
Publicado: (2012)

The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis
por: Gao, Peng, et al.
Publicado: (2017)

Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system
por: Liu, Li-Yu D, et al.
Publicado: (2014)

Therapeutic Potential of Highly Selective A(3) Adenosine Receptor Ligands in the Central and Peripheral Nervous System
por: Coppi, Elisabetta, et al.
Publicado: (2022)

Signal transducer and activator of transcription 3 (STAT3) signaling in retinal pigment epithelium cells
por: Patel, Amit K, et al.
Publicado: (2013)

Modulation of Tumor Tolerance in Primary Central Nervous System Malignancies
por: Johnson, Theodore S., et al.
Publicado: (2012)

Chronic Viral Infection and Primary Central Nervous System Malignancy
por: Saddawi-Konefka, Robert, et al.
Publicado: (2010)

Renal function in children treated for central nervous system malignancies
por: Musiol, Katarzyna, et al.
Publicado: (2016)

Potassium Ion Channels in Malignant Central Nervous System Cancers
por: Boyle, Yasmin, et al.
Publicado: (2022)

Viral Infections of the Central Nervous System: Pathogenesis to Therapeutics
por: Soldan, Samantha S., et al.
Publicado: (2010)

Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
por: Sun, Yun, et al.
Publicado: (2021)

Central Nervous System Therapeutic Targets in Friedreich Ataxia
por: Harding, Ian H., et al.
Publicado: (2020)

Signal Transducer and Activator of Transcription 4 in Liver Diseases
por: Wang, Yan, et al.
Publicado: (2015)

Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System
por: Carpanini, Sarah M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_238lhtehs61ek5oe6bqv1vug6q